Insider · CIK 0001754371
Jennifer E. Cook
director
Files at JAZZ (Jazz Pharmaceuticals plc), DNLI (Denali Therapeutics Inc.), BBIO (BridgeBio Pharma, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | JAZZ Jazz Pharmaceuticals plc | FTax withholding Ordinary Shares | -14 | $244.06 | $3,417 | 12,428 | 40 d ago |
| Aug 31, 2026 | JAZZ Jazz Pharmaceuticals plc | FTax withholding Ordinary Shares | -1,692 | $241.39 | $408k | 10,736 | 40 d ago |
| Aug 7, 2025 | JAZZ Jazz Pharmaceuticals plc | AGrant or award Ordinary Shares | +3,507 | $0.00 | $0 | 12,642 | Aug 11, 2025 |
| Aug 8, 2025 | JAZZ Jazz Pharmaceuticals plc | FTax withholding Ordinary Shares | -1,805 | $111.25 | $201k | 10,837 | Aug 11, 2025 |
| Jun 20, 2025 | BBIO BridgeBio Pharma, Inc. | AGrant or award Common Stock | +6,589 | $0.00 | $0 | 13,741 | Jun 24, 2025 |
| Jun 20, 2025 | BBIO BridgeBio Pharma, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +8,425 | $0.00 | $0 | 8,425 | Jun 24, 2025 |
| Jun 3, 2025 | DNLI Denali Therapeutics Inc. | AGrant or award Common Stock | +6,037 | $0.00 | $0 | 26,075 | Jun 5, 2025 |
| Jun 3, 2025 | DNLI Denali Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +18,111 | $0.00 | $0 | 18,111 | Jun 5, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.